Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · IEX Real-Time Price · USD
76.06
-0.88 (-1.14%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.27 billion as of July 2, 2024. Its market cap has increased by 63.35% in one year.
Market Cap
8.27B
Enterprise Value
6.82B
1-Year Change
63.35%
Ranking
Category
Stock Price
$76.06
Market Cap Chart
Since June 12, 2020, Vaxcyte's market cap has increased from $1.22B to $8.27B, an increase of 576.78%. That is a compound annual growth rate of 60.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 8.37B | 40.08% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.57% |
| Dec 31, 2021 | 1.26B | -7.23% |
| Dec 31, 2020 | 1.35B | 10.71% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Globus Medical | 9.21B |
| AptarGroup | 9.18B |
| Qiagen | 8.91B |
| Solventum | 8.89B |
| Encompass Health | 8.60B |
| Legend Biotech | 8.40B |
| Henry Schein | 8.32B |
| Chemed | 8.17B |